The present study showed that infiltration/expression levels of CD4 and CD8‐positive T lymphocytes and TGFβ1 and SMAD3 were associated with survival from the initiation of the combined therapy with chemotherapy plus immune checkpoint inhibitors in patients with SCLC. Here, SMAD3 is linked to small cell lung carcinoma.